The board of the Global Fund to Fight AIDS, Tuberculosis and Malaria began a two-day meeting in Geneva on Thursday, “with one topic high on the agenda: a new funding model,” Devex’s “Development Newswire” reports. “The board will tackle aspects of a new funding model, which, according to Global Fund Director of Communications Seth Faison, ‘will change the way the Global Fund has made grants for 10 years,'” the news service writes, adding that the model, according to the International HIV/AIDS Alliance, “will see the Global Fund dropping its ’round’ grant-making process and replacing it with a ‘more flexible’ system.” In addition, “an ‘iterative dialogue process’ is also reportedly being explored,” Devex reports. “The proposed reforms seem good for the fund and its beneficiaries … [b]ut some have expressed their concerns on the funding model under consideration, specifically on the ‘historical disease application’ approach,” the news service writes (Ravelo, 9/13). According to an article on the Stop TB Partnership website, the new approach “would cap the proportion of funding available to tuberculosis (TB) projects at 16 percent,” and the proposal, “which is based on the proportion of grants awarded to TB in the past, met with strong objections from the community of people working on TB worldwide” (9/13).
Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), and Kate McQueston, a program coordinator at CGD, write in the center’s “Global Health Policy” blog that a reduction in AIDS funding to Ethiopia from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria “might be warranted due to epidemiological trends and improved efficiency, or might cripple progress as health programs dependent on external donors are cut back,” but “with the current poor status of basic information on beneficiaries and costs, it’s difficult to judge whether these cuts are good or bad.” They outline the history of AIDS funding in Ethiopia, posit what future funding might encompass, and say additional information is needed from PEPFAR, the Global Fund, and the Ethiopian government in order to know the true impacts of reduced funding (9/11).
In this episode of the Center for Global Development’s (CGD) “Global Prosperity Wonkcast,” CGD’s Lawrence MacDonald interviews Amanda Glassman, a senior fellow and director of the global health policy program at the center, about global health funding in “this austere budget climate.” In an accompanying blog post, MacDonald notes “generating ‘value for money’ (VFM) is a top concern for global health funding agencies and their donors, who want the biggest bang for their buck in terms of lives saved and diseases controlled.” According to the blog, the discussion focuses on the Global Fund to Fight AIDS, Tuberculosis and Malaria, “a multilateral agency that emerged from the G8 meeting process in 2002 when times were better and global health was seen as an area where money could make a difference” (9/5).
The Affordable Medicines Facility-malaria (AMFm) — an innovative financing mechanism that subsidizes the cost of artemisinin-based combination therapies (ACTs) in order to expand access to the most effective treatment for malaria — “brought more than 100 million doses of malaria drugs to clinics and pharmacies in 2011” and “also increased access to the top malaria medicines by 26 to 52 percent in six countries,” according to results from the first phase of the program, which is hosted and managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria, NPR’s “Shots” blog reports. The results of the evaluation, released on Wednesday in Washington, D.C., do not estimate how many lives were saved because of improved access to effective malaria medications, as “AMFm ran for only a year and half in most countries,” according to the blog. “The AMFm negotiated with drugmakers to reduce ACTs prices, and then the Global Fund subsidized the initial purchasing of the drugs by clinics and pharmacies,” the blog notes.
The Global Fund to Fight AIDS, Tuberculosis and Malaria has published Issue 8 of its newsletter, the “Global Fund News Flash.” The issue reports on the Board’s approval of a new funding approach; says “the Board extended the mandate of the Global Fund to host the Affordable Medicines Facility-malaria for another year after the end of its pilot phase in December”; notes the Global Fund adopted a code of conduct for grant recipients; and profiles Linda Mafu, head of civil society and political advocacy at the Global Fund (9/20).
“Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on … the multilateral organization,” the Center for Global Health Policy’s “Science Speaks” blog reports. Benn spoke about staffing changes at the Fund, the organizations’ new risk management framework and the Transitional Funding Mechanism (TFM), and the Obama Administration’s proposed FY 2013 budget request, according to the blog (Mazzotta, 4/4).
Two separate posts in the Center for Global Health Policy’s “Science Speaks” blog report on the International Treatment as Prevention conference in Vancouver. The first post recaps an update from Stephen Becker of the Bill & Melinda Gates Foundation on Tuesday “about the Foundation’s treatment optimization activities,” writing, “According to Becker, the Foundation acknowledges that treatment will be at the center of HIV prevention efforts, but ‘no amount of treatment will obviate the need for primary prevention modalities'” (Lubinski, 4/24). The second post reports that, “[d]espite its status as one of the poorest countries in Africa and its failed effort to garner a Round 10 grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria — Malawi is moving forward to implement ‘Option B+’ for pregnant women,” meaning “pregnant and lactating women are enrolled in antiretroviral therapy (ART) programs for life, regardless of CD4 count” (Lubinski, 4/24).
“[T]he newly appointed temporary General Manager Gabriel Jaramillo and his team has moved forward to ‘transform’ the Global Fund [to Fight AIDS, Tuberculosis and Malaria] with considerable speed and deftness, restoring confidence among bilateral donors (such as Japan and several others) and country recipients as well as improving morale among the Fund’s staff,” Victoria Fan, a research fellow at the Center for Global Development (CGD), writes in CGD’s “Global Health Policy” blog. She explores some of the changes at the Global Fund and how “these changes help the Fund to achieve better health outcomes.” Fan writes, “In particular, I am very encouraged about the prospect of two changes: (1) the creation of a new Division called ‘Strategic Investment and Impact Evaluation’ which will shape the optimal portfolio of investments by country and disease …, and (2) the creation of new committees for each disease (AIDS, Tuberculosis, and Malaria) that will meet monthly” (4/25).
Wednesday, April 25, marked World Malaria Day, which this year had the theme “Sustain Gains, Save Lives: Invest in Malaria.” The following opinion pieces address the fight against malaria.
“Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is ‘not in crisis,'” Inter Press Service reports, referring to comments made by the organization’s deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year’s allegations of mismanagement, the news service adds.